These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 775519)

  • 1. [Current views on the action of chlorpromazine].
    Kanabus P
    Psychiatr Pol; 1976; 10(2):189-95. PubMed ID: 775519
    [No Abstract]   [Full Text] [Related]  

  • 2. A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
    Narasimhachari N; Lin RL
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):341-51. PubMed ID: 4527612
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver.
    Tavoloni N; Boyer JL
    J Pharmacol Exp Ther; 1980 Aug; 214(2):269-74. PubMed ID: 7391977
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorpromazine metabolism and clinical response in acute schizophrenia: a preliminary report.
    Schooler NR; Sakalis G; Chan TL
    Psychopharmacol Bull; 1975 Oct; 11(4):30-3. PubMed ID: 1105639
    [No Abstract]   [Full Text] [Related]  

  • 5. The assay of chlorpromazine and metabolites in blood, urine, and other tissues.
    Usdin E
    CRC Crit Rev Clin Lab Sci; 1971 Sep; 2(3):347-91. PubMed ID: 4942646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Level of free and bound chlorpromazine fractions in the blood and urine during chlorpromazine treatment].
    Nurowska K; Szajbel W; Waszkiewicz E; Welbel L
    Psychiatr Pol; 1970; 4(4):435-42. PubMed ID: 5472581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Structure of excretion products of 3,7-dimethyl-1-(5-oxo-hemyl)-xanthine (BL 191) in man].
    Hinze HJ; Bedessem G; Söder A
    Arzneimittelforschung; 1972 Jul; 22(7):1144-51. PubMed ID: 4678121
    [No Abstract]   [Full Text] [Related]  

  • 8. Red blood cell drug binding as a possible mechanism for tranquilization.
    Manian AA; Piette LH; Holland D; Grover T; Leterrier F
    Adv Biochem Psychopharmacol; 1974; 9(0):149-61. PubMed ID: 4365629
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treatment of schizophrenia.
    Hollister LE
    Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic aspects of chlorpromazine metabolism.
    Grant FW
    Recent Adv Biol Psychiatry; 1968; 10():16-9. PubMed ID: 5658705
    [No Abstract]   [Full Text] [Related]  

  • 11. A new method for measuring minute amounts of chlorpromazine and some of its metabolites in plasma.
    Efron DH; Gaudette LE; Harris SR
    Agressologie; 1968; 9(1):103-7. PubMed ID: 5681810
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literature.
    Wyatt RJ
    Psychopharmacol Bull; 1976 Jul; 12(3):5-50. PubMed ID: 959470
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbohydrate metabolism in brain diseases. X. Lack of effect of chlorpormazine and reserpine on abnormal carbohydrate metabolism in chronic schizophrenia.
    ALTSCHULE MD; GONCZ RM; HOLLIDAY PD
    AMA Arch Intern Med; 1957 Jun; 99(6):892-5. PubMed ID: 13423919
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine excretion. III. Fecal excretion of 14C-chlorpromzine in chronically dosed patients.
    Georgotas A; Serra MT; Green DE; Perel JM; Gershon S; Forrest IS
    Commun Psychopharmacol; 1979; 3(3):197-202. PubMed ID: 498751
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of fendiline metabolites in human urine.
    Benthe HF; Thieme RA
    Biomed Mass Spectrom; 1983 Feb; 10(2):65-73. PubMed ID: 6838997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and saliva levels of chlorpromazine and subjective response.
    Van Putten T; May PR; Jenden DJ; Cho AK; Yale C
    Am J Psychiatry; 1980 Oct; 137(10):1241-2. PubMed ID: 7416274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Place of clinical and pharmacokinetic parameters in prognosing the effectiveness of schizophrenic therapy].
    Panteleeva GP; Minsker EI; Tsirkin SIu; Beliaev BS; Lukanina SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):748-54. PubMed ID: 7415697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine and chlorpromazine in hepatic microsomal systems.
    Perel JM; O'Brien L; Black NB; Bellward GD; Dayton PG
    Adv Biochem Psychopharmacol; 1974; 9(0):201-12. PubMed ID: 4836204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biotransformation of Chlorphenethazin (Elroquil, Marophen)].
    Pfeifer S; Franke P
    Pharmazie; 1985 Jan; 40(1):37-9. PubMed ID: 2859615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolsm of chlorpromazine. V. Confirmation of position 7 as the major site of hydroxylation.
    Goldenberg H; Fishman V
    Biochem Biophys Res Commun; 1964; 14():404-7. PubMed ID: 5836534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.